Please login to the form below

Not currently logged in

Rosetta merges with Razorfish Healthware to launch new agency

Merger will create Razorfish Health
Razorfish logo

Publicis Healthcare Communications Group (PHCG) has revealed that part of Rosetta's healthcare business is to merge into Razorfish Healthware to create Razorfish Health.

The engagement, creative and media segment of Rosetta's healthcare business will merge in the US with PHCG's existing agency, Razorfish Healthware.

Nick Colucci, CEO of PHCG, commented: “As health and wellness clients grapple with the accelerating transformation of healthcare in a digital world, the new Razorfish Health is ideally positioned to bring its combined expertise in engagement, innovation and technology to deliver better health outcomes for our clients.”

Rosetta's healthcare business, in regards to commerce, enterprise technology platforms and growth strategy consulting will remain at Rosetta under its East Region.
Shannon Hartley, previous leader of Rosetta's Healthcare Industry Group, will take the role of managing director of Razorfish Health, taking over US operations.

The new agency will report to PHCG president Janet Winkler, who additionally oversees North American operations of Saatchi & Saatchi Wellness, in-sync Customer Insights, Discovery USA, Maxcess and Verilogue.

Article by
Kirstie Pickering

25th February 2015

From: Sales, Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...